MHRA report “Some newly issued vials of intravenous dantrolene may contain crystals of undissolved dantrolene sodium following reconstitution. Draw up the reconstituted solution with a filter needle to prevent these crystals from being administered to patients. There may be a residual increased risk of injection site reactions due to crystals that may not have been removed by filtration; heightened vigilance is therefore required.”
Drug alert: Intravenous dantrolene and the risk of undissolved crystals http://ctt.ec/HPW21+ @ivteam #ivteam
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.